Adaptive Optics Ophthalmoscopy for Glaucoma
About the Research Project
Program
Award Type
Standard
Award Amount
$70,000
Active Dates
April 01, 2004 - March 31, 2006
Grant ID
G2004039
Past Principal Investigator(s)
Austin Roorda, PhD , University of California, Berkeley
Summary
The adaptive optics scanning laser ophthalmoscope is a new instrument that has been developed at the University of Houston for the microscopic imaging of living human eyes. Dr. Roorda is employing this instrument to study the microscopic changes in the eyes of monkeys that have experimentally-induced glaucoma. His goal is to establish a timeline of the microscopic changes in the ganglion cells (a type of nerve cell that exists in the optic nerve) and in the optic disk that occur during the progression of glaucoma. These findings will be correlated with data related to visual field loss and electric response changes in the monkey eye. Dr. Roorda then hopes to build on these animal studies by using the same techniques to image and monitor glaucoma in human eyes.
Related Grants
National Glaucoma Research
Developing New Drugs for Glaucoma
Active Dates
January 01, 2026 - December 31, 2027
Principal Investigator
Pete Williams, PhD
Current Organization
Karolinska Institutet
Developing New Drugs for Glaucoma
Active Dates
January 01, 2026 - December 31, 2027
Principal Investigator
Pete Williams, PhD
Current Organization
Karolinska Institutet
National Glaucoma Research
Developing a New Glaucoma Treatment That Avoids Daily Drops
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Gavin Roddy, MD, PhD
Current Organization
Mayo Clinic, Rochester
Developing a New Glaucoma Treatment That Avoids Daily Drops
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Gavin Roddy, MD, PhD
Current Organization
Mayo Clinic, Rochester
National Glaucoma Research
Human Retinal Regeneration to Cure Glaucoma
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Karl Wahlin, PhD
Current Organization
University of California, San Diego
Human Retinal Regeneration to Cure Glaucoma
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Karl Wahlin, PhD
Current Organization
University of California, San Diego